- Home
- STEM vs CRBP Comparison
STEM vs CRBP Comparison
Compare STEM & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEM
- CRBP
- Stock Information
- Founded
- STEM 2009
- CRBP 2009
- Country
- STEM United States
- CRBP United States
- Employees
- STEM N/A
- CRBP N/A
- Industry
- STEM Computer Software: Prepackaged Software
- CRBP Biotechnology: Pharmaceutical Preparations
- Sector
- STEM Technology
- CRBP Health Care
- Exchange
- STEM Nasdaq
- CRBP Nasdaq
- Market Cap
- STEM 75.7M
- CRBP 73.4M
- IPO Year
- STEM N/A
- CRBP N/A
- Fundamental
- Price
- STEM $0.50
- CRBP $8.30
- Analyst Decision
- STEM Hold
- CRBP Strong Buy
- Analyst Count
- STEM 9
- CRBP 10
- Target Price
- STEM $1.17
- CRBP $53.56
- AVG Volume (30 Days)
- STEM 3.1M
- CRBP 118.0K
- Earning Date
- STEM 04-29-2025
- CRBP 05-06-2025
- Dividend Yield
- STEM N/A
- CRBP N/A
- EPS Growth
- STEM N/A
- CRBP N/A
- EPS
- STEM N/A
- CRBP N/A
- Revenue
- STEM $151,627,000.00
- CRBP N/A
- Revenue This Year
- STEM $5.72
- CRBP N/A
- Revenue Next Year
- STEM $19.61
- CRBP $150.00
- P/E Ratio
- STEM N/A
- CRBP N/A
- Revenue Growth
- STEM N/A
- CRBP N/A
- 52 Week Low
- STEM $0.29
- CRBP $4.64
- 52 Week High
- STEM $1.68
- CRBP $61.90
- Technical
- Relative Strength Index (RSI)
- STEM 49.18
- CRBP 63.45
- Support Level
- STEM $0.45
- CRBP $7.05
- Resistance Level
- STEM $0.50
- CRBP $7.62
- Average True Range (ATR)
- STEM 0.05
- CRBP 0.53
- MACD
- STEM -0.01
- CRBP 0.03
- Stochastic Oscillator
- STEM 53.36
- CRBP 96.31
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.